MBX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$5,347.50
Insider Selling (Last 12 Months): C$82,289.50

Microbix Biosystems Insider Trading History Chart

This chart shows the insider buying and selling history at Microbix Biosystems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Microbix Biosystems Share Price & Price History

Current Price: C$0.37
Price Change: Price Decrease of -0.01 (-2.67%)
As of 02/1/2023 01:00 AM ET

This chart shows the closing price history over time for MBX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Microbix Biosystems Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/6/2022Peter Martin BlecherDirectorSell23,500C$0.52C$12,149.501,747,700
7/20/2022Cameron Lionel GroomeDirectorSell65,000C$0.52C$33,540.00625,000
5/17/2022Kenneth HughesSenior OfficerBuy11,500C$0.47C$5,347.50316,500
2/16/2022Cameron Lionel GroomeDirectorSell60,000C$0.61C$36,600.00315,000
12/30/2021James Stuart CurrieSenior OfficerSell14,500C$0.83C$12,035.00180,500
11/24/2021James Stuart CurrieSenior OfficerSell50,000C$0.68C$33,950.00275,000
11/16/2021Martin MarinoDirectorSell50,000C$0.73C$36,500.001,115,000
6/25/2021Martin MarinoDirectorBuy50,000C$0.54C$27,000.00251,667
6/23/2021Cameron Lionel GroomeDirectorBuy15,000C$0.55C$8,250.00215,000
4/13/2021Martin MarinoDirectorBuy35,000C$0.62C$21,700.0035,000
1/14/2021Cameron Lionel GroomeDirectorBuy11,000C$0.44C$4,791.60200,000
12/29/2020Mark Adrian LuscherSenior OfficerBuy28,270C$0.43C$12,014.75159,670
11/26/2020Peter Martin BlecherDirectorBuy9,000C$0.40C$3,600.00837,274
11/24/2020Peter Martin BlecherDirectorBuy129,500C$0.36C$46,620.00744,707
11/13/2020Kenneth HughesSenior OfficerBuy1,000C$0.35C$348.00261,500
11/11/2020Kenneth HughesSenior OfficerBuy500C$0.34C$167.50260,500
11/9/2020Martin MarinoDirectorBuy50,000C$0.38C$18,900.0050,000
11/3/2020Cameron Lionel GroomeDirectorBuy50,000C$0.36C$18,000.001,000,000
9/1/2020Cameron Lionel GroomeDirectorBuy25,000C$0.26C$6,500.00175,000
8/28/2020Cameron Lionel GroomeDirectorBuy50,000C$0.26C$13,000.00950,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Microbix Biosystems (TSE:MBX)

Microbix Biosystems logo
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.
Read More on Microbix Biosystems

Today's Range

Now: C$0.37
Low: C$0.37
High: C$0.37

50 Day Range

MA: C$0.41
Low: C$0.37
High: C$0.47

52 Week Range

Now: C$0.37
Low: C$0.37
High: C$0.70


14,600 shs

Average Volume

20,767 shs

Market Capitalization

C$50.73 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Microbix Biosystems?

Microbix Biosystems' top insider shareholders include:
  1. Peter Martin Blecher (Director)
  2. Martin Marino (Director)
  3. Cameron Lionel Groome (Director)
  4. Kenneth Hughes (Senior Officer)
  5. James Stuart Currie (Senior Officer)
Learn More about top insider investors at Microbix Biosystems.